M. O. Silkina

M. O. Silkina

Auto-generated profile, based on publicly available information

M. O. Silkina

National Research University “Higher School of Economics

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2024 in Cancer Urology
Verified
Journal Article
Open access
PDF file
SNSergey Nikulin
Sergey Nikulin
MSM. O. Silkina
M. O. Silkina
ARA. V. Razumovskaya
A. V. Razumovskaya
MRMaria Raigorodskaia
Maria Raigorodskaia
BAB. Ya. Alekseev
B. Ya. Alekseev
Background. Analyzing the sensitivity of patient-derived tumor organoids to anti-cancer medications shows great potential for tailoring personalized treatment plans.Aim. To obtain two prostate tumor organoid cultures, optimize the composition of culture medium, and to evaluatethe efficacy of the chemotherapeutic drug docetaxel using the obtained organoid cultures.Materials and methods. The initial tissue was dissociated using the gentleMACS Octo homogenizer. The obtained cells were cultured in Matrigel with different culture media for selection of the optimal one. Cell viability and growth rates were assessed using the MTS assay.Results. In this study, we successfully obtained two organoid cultures of prostate cancer cells and identified the most effective composition of culture medium. Using a cytotoxic test, it was shown that the obtained organoid cultures of prostate cancer cells had different sensitivity to docetaxel which was reflected in different inhibition of the tumor cell growth rate.Conclusion. The utilization of prostate cancer organoids to determine the best treatment approach is a highly promising experimental technology. Nevertheless, additional research is required before integration of this technology into clinical practice.